Clinical trial
Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II)
NCT00289042 · The Cleveland Clinic, Other · Completed
Key facts
| NCT number | NCT00289042 |
|---|---|
| Title | Assessment of Cardioversion Using Transesophageal Echocardiography II (ACUTE II) |
| Official title | The Use of Enoxaparin Compared to Unfractionated Heparin for Short Term Antithrombotic Therapy in Atrial Fibrillation Patients Undergoing TEE Guided Cardioversion: Assessment of Cardioversion Using Transesophageal Echocardiography (ACUTE) II Randomized Multicenter Study |
| Lead sponsor | The Cleveland Clinic, Other |
| Collaborators | Sanofi Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Atrial Fibrillation |
| Intervention type | Drug |
| Interventions | Enoxaparin |
| Enrollment | 200 |
| Start date | Dec 1, 1999 |
| Completion | Nov 1, 2004 |
| First posted | Feb 9, 2006 |
| Last update posted | Jan 31, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: